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Abstract
Objective To evaluate the clinical and economic burden associated with anastomotic leaks following colorectal surgery.
Methods Retrospective data (January 2008 to December 2010) were analyzed from patients who had colorectal surgery with and
without postoperative leaks, using the Premier Perspective™ database. Data on in-hospital mortality, length of stay (LOS), re-
admissions, postoperative infection, and costs were analyzed using univariate and multivariate analyses, and the propensity score
matching (PSM) and generalized linear models (GLM).
Results Of the patients, 6,174 (6.18 %) had anastomotic leaks within 30 days after colorectal surgery. Patients with leaks had 1.3
times higher 30-day re-admission rates and 0.8–1.9 times higher postoperative infection rates as compared with patients without
leaks (P<0.001 for both). Anastomotic leaks incurred additional LOS and hospital costs of 7.3 days and $24,129, respectively,
only within the first hospitalization. Per 1,000 patients undergoing colorectal surgery, the economic burden associated with
anastomotic leaks—including hospitalization and re-admission—was established as 9,500 days in prolonged LOS and $28.6
million in additional costs. Similar results were obtained from both the PSM and GLM for assessing total costs for hospitalization
and re-admission.
Conclusions Anastomotic leaks in colorectal surgery increase the total clinical and economic burden by a factor of 0.6–1.9 for a
30-day re-admission, postoperative infection, LOS, and hospital costs.
Keywords Postoperative anastomotic leak . Colorectal
surgery . Health economics . Length of stay . Cost
Introduction
Anastomotic leaks are one of the most serious complications
that occur after gastrointestinal surgery. They add to potential
postoperative patient morbidities and to overall costs of post-
operative patient care, including associated hospital re-
admissions. Further, reoperations and complications such as
leaks are considered a quality indicator in colorectal surgery.1
Patients developing anastomotic leaks after undergoing co-
lorectal resection exhibit poorer long-term functional results; in
the case of malignancy, increased local recurrence rates and
reduced 5-year survival are seen.2–4 The clinical manifestations
of anastomotic leaks will often warrant hospital re-admission,
placing a considerable additional burden on patients and
healthcare providers. Overall, anastomotic leaks after colorectal
surgery have devastating implications, with significantly greater
chances of wound infection andmortality rates of up to 32%.5, 6
In addition to potential negative clinical outcomes, there is
a significant economic and healthcare utilization burden to be
considered.While postoperative complications have a dramat-
ic impact on full in-hospital costs per case and are the stron-
gest indicator of costs,7 there remains a gap in the literature in
pairing clinical sequelae of postoperative anastomotic leaks to
economic outcomes.
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Reported leak rates for colorectal surgery range from 1.5 to
16 % globally; however, definitions of leaks differ between
published studies.8 Furthermore, a review by Kingham and
Pachter reported that experienced colorectal surgeons often
quote 3 to 6 % as a generally acknowledged overall leakage
rate. They also compared the definitions across different stud-
ies and concluded that there was no uniformly accepted set of
criteria.9 They observed that definitions varied based on com-
binations of clinical signs, biochemical markers, radiological
findings, and intraoperative findings. Our focus was on clin-
ical leaks, as they affect morbidity and mortality. Nonclinical
leaks diagnosed by radiology have no clinical effects and
resolve without interventions. Our study was undertaken to
quantify the incidence of anastomotic leaks in patients under-
going colorectal surgery and to assess the clinical and eco-
nomic burden of anastomotic leaks in terms of extended
hospital stay, re-admissions, in-hospital mortality, postopera-
tive infection, and total costs following colorectal surgery.
Methods
Study Design
This study was designed as a retrospective data analysis of
hospital-based patients to analyze the health outcomes and
medical resource utilization of patients with anastomotic leaks
following colorectal surgery.
Database and Sample Selection
Matched and unmatched cohort studies were conducted retro-
spectively, utilizing hospital administrative data from the
Premier Perspective™ database (Premier, Inc., Charlotte,
NC, USA) from January 2008 to December 2010.10 This
database contains complete clinical coding, hospital cost,
and patient billing data frommore than 600 hospitals through-
out the USA. Furthermore, it collects data from participating
hospitals in its healthcare alliance. The Premier healthcare
alliance was formed for hospitals to share knowledge, im-
prove patient safety, and reduce risks. Participation in the
Premier healthcare alliance is voluntary. The hospitals includ-
ed are nationally representative based on bed size, geographic
location, and teaching hospital status.11 The database contains
a date-stamped log of all billed items by the cost-accounting
department, including medications; laboratory, diagnostic,
and therapeutic services; and primary and secondary diagno-
ses for each patient’s hospitalization. Identifier-linked enroll-
ment files provide demographic and payer information.
Detailed service-level information for each hospital day was
recorded; this included details on medication received.
The patient information collected included patient demo-
graphics (age, gender, race/ethnicity), clinical characteristics
(All Patient Refined Diagnosis Related Groups [APR-DRG]
severity, APR-DRG risk of mortality, Charlson Comorbidity
Index [CCI]), hospital and admitting characteristics (location
and region of hospital, number of beds, teaching status, ad-
mission type), primary and secondary diagnoses, primary and
secondary procedures, payer, length of stay (LOS), cost of
care, drug utilization, department cost and charge details, day-
of-stay capture for some variables, and physician specialty.
The APR-DRG, a widely accepted healthcare research meth-
odology developed by 3M, is an indicator of the severity
degree of a disease; it is classified into four categories—
minor, moderate, major, and extreme. For the purpose of this
study, Version 26 of the APR-DRG was used. The CCI is a
tool used to predict the 10-year mortality for a patient who
may have a range of comorbid conditions. Data from all payer
types were included. Laboratory/culture data were not avail-
able for this study.
Inclusion/Exclusion Criteria
Data on patients ≥18 years of age, who had undergone surgery
on the colon or rectum and with colon or rectal anastomosis,
were included in the study. All eligible patients underwent
colorectal surgery, first performed during the study period.
The surgeries considered for inclusion were colectomy,
hemicolectomy, or rectum resection, and were identified by
International Classification of Diseases, version 9 (ICD-9)
procedure codes, Current Procedural Terminology (CPT)
codes, and Perspective Standard Charge Master codes.
Excluded from the study were patients who were under
18 years of age, admitted for trauma-related diagnoses, had
an LOS of 0 during the timeframe under study, and patients
with a missing index colorectal surgery day. Also excluded
were patients with a protective ostomy, i.e., an ostomy as part
of the index procedure.
Outcome Measures
The primary objectives of this study were to examine the
incidence of anastomotic leaks following colorectal surgery
and to evaluate the associated clinical and economic burden.
Anastomotic leaks were defined by re-operation, re-
anastomosis, stent, colostomy, drainage, and/or abscess within
a 30-day window following colorectal surgery, and were
identified by ICD-9 procedure codes, CPT codes, and
Perspective Standard Charge Master codes. These re-
intervention codes were selected because they are specific or
suggestive of procedures surgeons would follow when faced
with a clinically apparent anastomotic leak.
The total costs of hospitalization, including re-admission
(if applicable), and by-department costs, were recorded and
analyzed. The cost variable we chose represented the actual
cost to treat the patient and included all supplies, labor, and
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depreciation of equipment. The cost was calculated by adding
the variable costs (direct) and the fixed costs (overhead) in the
Premier Perspective™ database. In addition, data were ana-
lyzed on in-hospital mortality (hospitalization and re-
admission, individually and combined) and postoperative in-
fection during hospitalization. The definitions used for post-
operative infection were based on ICD-9 codes 998.5X and
998.6X, and on nonprophylactic antibiotic usage as a proxy
for postoperative infections, defined as postoperative expo-
sure to the predefined antimicrobial drugs ≥2 days after sur-
gery and with treatment duration ≥7 days.12 Data on discharge
status were recorded, including whether patients were
discharged to their home, a skilled nursing facility, other
institutions, or to a short-term general hospital; unknown
reasons and patients’ death were also recorded within the
discharge data. Data concerning hospital LOS and re-
admission within 30 days after discharge were recorded indi-
vidually and combined.
Covariates used for the analysis included anastomotic leaks
(as defined previously); age; race; gender; admission type;
CCI; type of colorectal index surgery (left colon/sigmoid,
right colon, colorectal); APR-DRG severity level; APR-




Descriptive analyses were conducted to show the overall
incidence of anastomotic leaks among the cohorts, patient
baseline demographic and clinical characteristics, and hospital
characteristics. Univariate analyses were performed to assess
the unadjusted difference in outcomes and covariates between
the two groups. Continuous measures (e.g., age) were sum-
marized by mean and standard deviation, and comparisons of
the differences in continuous measures between study groups
were made using the student t tests. Categorical variables were
summarized as proportions of the sample with the character-
istic and compared using chi-squared tests between study
groups. Comparison of continuous variables without normal
distribution (e.g., cost data) was performed using aWilcoxon–
Mann–Whitney nonparametric test.
Propensity Score Matching
The differences in the clinical and economic outcomes were
compared by adjusting for covariates using the propensity
score matching (PSM) method. The PSM method matched a
patient without anastomotic leaks to each of the patients with
leaks, using a 1:1 ratio and the nearest neighbor matching
algorithm, Parsons, which is the most frequently used
case/control matching algorithm.13 In addition, the nearest
available pair matching method was used. The cases were
ordered and sequentially matched to the nearest unmatched
control. If more than one unmatched control matched a case,
the control was selected at random. PSM utilizes the baseline
characteristics into a single index variable to facilitate the
desired matching. The likelihood of having an anastomotic
leak was estimated based on individual characteristics for each
patient with and without anastomotic leaks, using a binary
logistic regression model. Each case of anastomotic leaks was
then matched with a patient from the nonleak cohort who had
the closest propensity score to that of the case’s score. After
matching, comparisons between the cohorts were performed
on covariates and outcome variables using various statistical
tests as described above.
Multivariate Analysis
Generalized linear models (GLMs) were used to describe the
impact of the anastomotic leaks on economic outcomes in
patients with colorectal surgery, thereby confirming the results
from the PSM method on the economic outcomes. GLMs are
empirical transformations of classical linear (Gaussian) re-
gression models and are distinguished from Ordinary Least
Squares (OLS) by a particular model, rather than data trans-
formations. Healthcare expenditure and resource use data
frequently have a log-normal or gamma distribution, and
studies using GLM for cost and resource use analysis have
focused on the gamma response distribution.14 GLMs are the
preferred approach for multivariate analysis of cost data. In
order to analyze LOS data, negative binomial distribution was
used. All analyses were conducted using SAS version 9.2




Records of 101,929 patients who underwent colorectal sur-
gery from 2008 to 2010 were screened. A total of 99,879
records fit the inclusion criteria (Fig. 1). The mean (SD) age of
the patients was 63.1 (15.3) years, with 54% female and 46%
male. Differences were noted in baseline demographic and
clinical characteristics (Tables 1 and 2), and in age, sex, race,
and health plans between patients with and without anasto-
motic leaks (P<0.001 for all). Additionally, significant differ-
ences in clinical characteristics were observed between pa-
tients with and without leaks, including APR-DRG severity,
CCI, individual comorbidities, and surgery type. The overall
incidence rate for 30-day postoperative anastomotic leaks was
6.18 % (6,174 patients). Annual mean leak rates for 2008,
2009, and 2010were 5.69, 6.46, and 6.48%, respectively. The
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mean leak rate was higher for surgeries around the colorectal
area (6.54 %) than for those on the left (5.82 %) or right
(6.09 %) colon alone.
Clinical Outcomes
Mortality and Discharge Status
Univariate analysis of clinical outcomes showed significant
differences in in-hospital mortality for patients undergoing
index hospitalization or re-admission; when combined, mor-
tality was reported in 12 % of patients with anastomotic leaks
as compared to 4 % of patients without leaks (P<0.001).
However, after PSM, there were no statistically significant
differences in mortality between the two cohorts. The PSM
analysis showed significant differences in the discharge sta-
tus—the proportions of patients with and without anastomotic
leaks with a discharge status of “home,” “home with nursing
care,” and “nursing facility” were 31 and 40 %, 27 and 23 %,
and 28 and 24 %, respectively (Table 3).
Postoperative Infection
Postoperative infection was reported in 27 and 9 % of patients
with and without leaks, respectively (Fig. 2). Patients with
leaks reported a postoperative infection rate that was 0.8–1.9
times higher than that of patients without leaks (P<0.001).
The subsequent 30-day re-admission was reported in 29 %
and 13 % of patients with and without leaks, respectively
(P<0.001; Fig. 2). When defined by nonprophylactic antibi-
otic use only, 58 and 33 % of patients with and without leaks,
respectively, reported postoperative infection (P<0.001).
Table 3 examines the clinical outcomes of patients with leaks
and matched controls.
Reasons for Re-admission
The primary reasons for re-admission of patients with and
without anastomotic leaks included surgical site infection
(25 vs 10 %), and gastrointestinal (22 % in both groups) and
genitourinary (5 vs 7 %) causes. Overall, 14 % of re-
admissions were related to complications of surgical and
medical care. Table 4 shows the primary reasons for re-
admission in patients with and without leaks.
Economic Outcomes and Hospitalization
The unmatched univariate analysis showed significant dif-
ferences in mean LOS between patients with and without
leaks (23 vs 9.7 days; P<0.001). For all patients with and
Fig. 1 Patient selection
Table 1 Demographics of pa-









Age, mean (SD) 63.1 (15.3) 63.2 (15.3) 61.2 (15.8) <0.001
Age
18–44 No. (%) 11,831 (12) 10,875 (12) 956 (15) <0.001
45–54 16,703 (17) 15,693 (17) 1,010 (16)
55–64 22,240 (22) 20,847 (22) 1,393 (23)
65+ 49,105 (49) 46,290 (49) 2,815 (46)
Sex
Female No. (%) 54,080 (54) 51,052 (54) 3,028 (49) <0.001
Male 45,796 (46) 42,650 (46) 3,146 (51)
Race
White No. (%) 69,610 (70) 65,406 (70) 4,204 (68) <0.001
Black 9,383 (9) 8,670 (9) 713 (12)
Other 20,886 (21) 19,629 (49) 2,815 (46)
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without leaks, the mean (SD) inpatient cost, including
index hospitalization and re-admission, was $27,966
($38,609), with a significant difference between mean costs
observed in patients with and without anastomotic leaks
($72,905 [$94,723] vs $25,005 [$29,256], respectively;
P<0.01).
Table 2 Baseline clinical charac-











Severity level of a patient for a specific APR-DRG
Minor No. (%) 23,539 (24) 23,162 (25) 377 (6) <0.001
Moderate 34,029 (34) 33,055 (35) 974 (16)
Major 24,386 (24) 22,801 (24) 1,585 (26)
Extreme 17,925 (18) 14,687 (16) 3,238 (52)
APR-DRG risk of mortality
Minor No. (%) 42,464 (43) 41,412 (44) 1,052 (17) <0.001
Moderate 25,583 (26) 24,506 (26) 1,077 (17)
Major 17,433 (17) 15,967 (17) 1,466 (24)
Extreme 14,399 (14) 11,820 (13) 2,579 (42)
Charlson Comorbidity Index, mean (SD) 2.5 (3.0) 2.5 (3.0) 2.6 (3.1) <0.001
Comorbidity
Comorbidity 0 No. (%) 35,457 (35) 33,423 (36) 2,034 (33) <0.001
Comorbidity ≥1 64,422 (65) 60,282 (64) 4,140 (67)
Type of index surgery
Left colon/sigmoid No. (%) 37,798 (38) 35,598 (38) 2,200 (36) <0.001
Right colon 19,596 (20) 18,402 (20) 1,194 (19)
Colorectal 42,485 (43) 39,705 (42) 2,780 (45)
Admission type
Emergency No. (%) 31,198 (31) 28,448 (30) 2,750 (45) <0.001
Urgent 10,370 (10) 9,568 (10) 802 (13)
Elective 57,969 (58) 55,375 (59) 2,594 (42)
Other 342 (0) 314 (0) 28 (0)
Health plan
Medicare No. (%) 49,119 (49) 46,206 (49) 2,913 (47) <0.001
Medicaid 5,218 (5) 4,704 (5) 514 (8)
Commercial 38,988 (39) 36,793 (39) 2,195 (36)
Other 6,554 (7) 6,002 (6) 552 (9)








In-hospital mortality for index hospitalization ONLY, No. (%) 1,295 (10) 649 (11) 646 (10) 0.93
Mortality of re-admission ONLY, No. (%) 114 (4) 46 (6) 68 (4) 0.014
Mortality of index hospitalization and re-admission, No. (%) 1,409 (11) 695 (11) 714 (12) 0.59
Discharge
Home No. (%) 4,397 (36) 2,500 (40) 1,897 (31) <0.001
Home with nursing care 3,120 (25) 1,425 (23) 1,695 (27)
Nursing facility 3,221 (26) 1,481 (24) 1,740 (28)
Expired 1,295 (10) 649 (11) 646 (10)
Other facility 309 (3) 116 (2) 193 (3)
Unknown 6 (0) 3 (0) 3 (0)
Postoperative infection, No. (%) 2,271 (18) 586 (9) 1,685 (27) <0.001
Infection defined by nonprophylactic antibiotic usage, No. (%) 25,079 (25) 20,949 (22) 4,130 (67) <0.001
1180 J Gastrointest Surg (2014) 18:1176–1185
After PSM, a number of significant differences were ob-
served in economic outcomes between patients with and
without leaks (Table 5). For patients with leaks, additional
average LOS increases of 7.3 days and hospital costs of
$24,129 were incurred for hospitalization alone. Patients with
leaks had a 1.3-fold greater chance of a 30-day re-admission.
After factoring in re-admissions, the average incremental
LOS and average incremental hospital cost increased by up
to 9.5 days and $28,597, respectively. The total LOS per
1,000 patients was 26,300 and 16,800 days in patients with
and without leaks, respectively (Fig. 3a). The resulting total
hospital costs per 1,000 patients were $72.9 million and
$44.3million for patients with and without leaks, respectively
(Fig. 3b). Population-level results demonstrated that incre-
mental burdens of anastomotic leaks in hospitalization and
re-admissions resulted in 9,500 days of increased LOS and
$28.6 million in additional payments.
After controlling for key covariates using a GLM, patients
with anastomotic leaks had 0.8 times (P<0.001) higher total
costs (of index hospitalization and re-admission) than patients
without leaks (Table 6).
Discussion
Anastomotic leaks remain a source of clinically significant
postoperative complications and are a risk factor for increased
morbidity and mortality. Our study sought to evaluate whether
anastomotic leaks influence economic and clinical outcomes
at a population level.
The overall incidence rate of anastomotic leaks in a 30-day
postoperative period was 6.18 %; similar annual rates were
observed for 2008, 2009, and 2010. Patients undergoing rectal
surgery had a slightly elevated risk of leaks than those under-
going right or left colon surgery. This is in agreement with
previous studies showing an increased incidence of leaks in
the rectal area.15–18 A prospective study examining 1,834
patients reported higher leak rates in patients undergoing
rectal/rectosigmoid surgeries (6.7 %) as compared to colonic
anastomoses (2.6 %).3 Regardless of location, these leaks
were often identified either in the late postoperative period
or after discharge. This might be attributed, in part, to hospi-
tals adapting early discharge protocols.19, 20 Our results also
showed differences in LOS and subsequent discharge for the
two cohorts, suggesting that the actual burden of leaks is larger
than the numbers captured in our analysis. However, our study
did not show statistically significant differences in mortality
between the two cohorts after PSM was applied. We believe
that this is due to nonleak-related mortality among high-risk
patients selected through PSM.
Diagnosing an anastomotic leak in an outpatient setting
may result in delayed intervention and may possibly adversely
affect patient outcomes.9, 21 In our study, 27% of patients with
anastomotic leaks had infections as compared with 9 % of
patients without leaks (Fig. 2). We used two definitions for
postoperative infection—one based on ICD-9 codes 998.5X/
998.6X and the other based on nonprophylactic antibiotic
Fig. 2 Postoperative infection and subsequent 30-day re-admission re-
ported in two groups of patients
Table 4 Reasons for a 30-day re-admission for patients with and without anastomotic leak






Gastrointestinal complications, No. (%) 2,393 (22) 2,001 (22) 392 (22)
Surgical site infection, No. (%) 1,380 (12) 935 (10) 445 (25)
Genitourinary, No. (%) 767 (7) 671 (7) 96 (5)
Cardiac/circulatory, No. (%) 524 (5) 486 (5) 38 (2)
Venous thromboembolism, No. (%) 819 (7) 733 (8) 86 (5)
Other infections, No. (%)a 769 (7) 661 (7) 108 (6)
Neurologic/nervous system, No. (%) 210 (2) 192 (2) 18 (1)
Aftercare and services for specific procedures, No. (%) 1,310 (12) 1,194 (13) 116 (6)
Complication of surgical and medical care, not elsewhere classified, No. (%) 1,528 (14) 1,172 (13) 356 (20)
Others, No. (%)b 2,146 (19) 1,904 (21) 242 (13)
a Other infections include septicemia- and intestinal infection-related complications
b Others include neoplasm-, endocrine-, and genitourinary-related complications
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usage as a proxy for postoperative infections, defined as
postoperative exposure to predefined antimicrobial drugs
2 days after surgery and with treatment duration ≥7 days.
Using prophylactic antibiotics as a proxy for postoperative
infection is previously documented—Yokoe et al. state that for
many clinicians, administering antibiotics to patients who
have recently undergone surgery indicates a suspicion of
surgical site infections and may indeed accurately reflect the
presence of infection when microbiologic confirmation is not
obtained.12 In our study, patients with leaks showed 0.8–1.9
times higher postoperative infections than patients without
leaks; this is consistent with previous studies.
In terms of economic impact, total inpatient costs were
considerably greater for patients with leaks as compared to
patients without leaks. Based on our results, patients with
leaks tend to spend almost a week more in a hospital, with
average incremental costs of $24,129 incurred for hospitali-
zation alone. Increased LOS in patients with leaks is an
expected result of the increased clinical sequelae. However,
earlier studies have used varying definitions for anastomotic
leaks. Our approach for defining leaks was unique in that our
focus was on all clinical anastomotic leaks as opposed to only
clinically significant anastomotic leaks (significance as de-
fined by the authors) or inclusion of occult leaks, defined in
earlier literature. While previous studies have defined leaks of
clinical significance, we believe any leak is significant by
virtue of being clinically apparent and requiring intervention.
Nonclinical leaks are occult and unseen, unless a routine (and
often unwarranted) scan is done, and are unlikely to seriously
influence morbidity and mortality. Bruce et al. have explored
the option of defining subclinical leaks;22 however, criteria for
defining these remain unclear. We eliminated subclinical anas-
tomotic leaks, as lack of clinical signs and symptoms trans-
lates into an occult leak.
In terms of patients requiring subsequent interventions, we
identified abdominal re-interventions within 2–30 days as
opposed to within 3–45 days postsurgically. We defined re-
intervention—as in the ICD-9 procedure codes and Premier
Perspective Charge Master codes—by re-operation, percuta-
neous drainage, stents, and radiology with drainage; radiology
was not entered as a stand-alone code, but coupled with
drainage. These re-interventions result in increased LOS or










30-day re-hospitalization, No. (%) 2,575 (21) 774 (13) 1,801 (29) <0.001
Length of stay for index hospitalization ONLY, mean (SD) 19.3 (20.6) 15.7 (16.7) 23.0 (23.3) <0.001
Total length of stay, re-admission ONLY, mean (SD) 10.6 (12.2) 8.8 (9.6) 11.3 (13.1) <0.001
Total length of stay, including index and re-admission BOTH, mean (SD) 21.5 (22.0) 16.8 (17.9) 26.3 (24.6) <0.001
Total cost ($) for index hospitalization ONLY, mean (SD) 54,415 (76,043) 42,350 (50,172) 66,479 (93,583) <0.001
Total inpatient cost ($), re-admission ONLY, mean (SD) 20,101 (25,568) 15,619 (21,206) 22,028 (27,006) <0.001
Total inpatient cost ($), including index and re-admission BOTH, mean (SD) 58,607 (77,788) 44,308 (52,168) 72,905 (94,723) <0.001
Cost ($) by department-lab, mean (SD) 4,150.6 (6,288.9) 3,225.2 (5,123.2) 5,076.0 (7,151.7) <0.001
Cost ($) by department-pharmacy, mean (SD) 8,320.7 (41,581) 5,849.4 (9276.5) 10,792 (57,965) <0.001
Cost ($) by department-radiology, mean (SD) 1,825.3 (2,424.4) 1,335.8 (1,886.2) 2,314.8 (2,778.5) <0.001
Cost ($) by department-other, mean (SD) 32,743 (43,414) 25,753 (33,799) 39,733 (50,297) <0.001
Fig. 3 a Total length of stay and b total hospital cost per 1,000 patients
with and without anastomotic leak
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re-admission. This slightly modified identification procedure
helped us analyze LOS and re-admissions in a more definitive
manner. Results for increased LOS were consistent with pre-
viously reported rates.
A study evaluating 56 patients undergoing colorectal sur-
gery found that patients showing symptomatic or clinical
evidence of anastomotic leaks had significantly longer dura-
tions of hospital stay when compared with those without leaks
(14±1.41 vs 5.43±0.89 days for patients with leaks and
without leaks, respectively).6 Another recent study by
Hashemi et al. sought to assess the economic impact of
anastomotic leaks after colectomy procedures.23 As in our
study, this study used information from the Premier
Perspective™ database and examined data from 2005 to
2009 of 46,788 patients with anastomotic leaks. Results for
mean hospital LOS were in agreement with our findings;
patients with leaks spent approximately 7 days more in a
hospital than those without leaks (14.9 vs 8.4 days). This
study also reported an increase in leak rates observed between
2005 and 2009 from 16.2 to 22.1 %. Further, mean costs per
discharge and overall inpatient costs were greater for patients
with anastomotic leaks.
While there were similarities in findings between the pre-
viously mentioned study and our study, some core differences
can be highlighted. The first is a variation in the methodolo-
gies used to identify the leaks themselves. The Hashemi study
did not specify what surgical procedures were selected among
ICD-9 codes, while our study specifically defined re-
intervention procedures such as re-operation, re-
anastomosis, stent, colostomy, drainage, and abscess within
a 30-day postoperative window, in addition to identifying
procedures by ICD-9 codes, CPT codes, and Perspective
Standard Charge Master codes. Another key differentiator
for our study was the use of both univariate and multivariate
analyses, and the GLM and PSM methods used for statistical
analyses. The use of multiple statistical methods and exami-
nation of matched and unmatched data for costs associated
with LOS provides further evidence of the considerable eco-
nomic burden associated with anastomotic leaks, in addition
to the attendant increase in morbidity.
Table 6 Generalized linear model for total cost of hospitalization plus re-admission
Variable Category Estimate-exp (B) Confidence interval P value
Intercept 40,733.373 (39,708.56, 41,784.63) <0.001
Anastomotic leak (ref=no leak) 1.802 (1.78, 1.83) <0.001
Agea 1.000 (1.00, 1.00) 0.222
Gender (ref=male) 0.969 (0.96, 0.98) <0.001
Race (ref=white) Black 1.079 (1.07, 1.09) <0.001
Hispanic 1.189 (1.17, 1.21) <0.001
Other 0.974 (0.97, 0.98) <0.001
Payer (ref=Medicare) Medicaid 1.065 (1.05, 1.08) <0.001
Commercial 0.984 (0.98, 0.99) <0.001
Other 0.982 (0.97, 1) 0.015
Medical stabilization (ref=no) Yes 1.316 (1.31, 1.33) <0.001
Admission type (ref=elective) Urgent 1.039 (1.03, 1.05) <0.001
Emergency 1.05 (1.04, 1.06) <0.001
Other 1.041 (0.99, 1.1) 0.145
Type of index surgery (ref=left/sigmoid) Right colon 0.273 (0.27, 0.28) <0.001
Colorectal 0.33 (0.33, 0.33) <0.001
Severity of illness (ref=extreme) Minor 0.483 (0.48, 0.49) <0.001
Moderate 0.273 (0.27, 0.28) <0.001
Major 0.33 (0.33, 0.33) <0.001
Number of beds (ref ≥500) <500 beds 1.062 (1.05, 1.07) <0.001
Geographic location of provider (ref=midwest) Northeast 1.129 (1.12, 1.14) <0.001
South 1.024 (1.01, 1.03) <0.001
West 1.165 (1.15, 1.18) <0.001
Location of the hospital (ref=urban) Rural 1.061 (1.05, 1.07) <0.001
Teaching hospital (ref=no) Teaching 1.083 (1.08, 1.09) <0.001
Charlson Comorbidity Indexa 1.005 (1, 1.01) <0.001
aAge and Charlson Comorbidity Index are continuous variables with no reference groups
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In this study, we used both PSM and GLM methods to
assess the effect of leaks on total costs by controlling for
observed confounders, and the results are consistent with each
other. These two methods differed in the assumptions and
analysis power (GLM assumed a linear structure of data and
PSM excluded control patients who did not meet the matching
criteria). Lastly, our study took into account re-admission due
to anastomotic leaks. While the previously mentioned studies
by Hashemi et al. and Fouda et al. have shown the significant
impact of anastomotic leaks on total costs, they did not exam-
ine the extent to which patients with leaks were readmitted and
the impact of re-admissions on costs. Re-admission places
significant increases in cost on an already burdened healthcare
system. Dor et al. estimate that the average unadjusted cost for
colectomy alone stands at $21,257; this number would in-
crease considerably when postsurgical complications such as
leaks are added,24 as observed in our study. Our results show
that patients with anastomotic leaks had a 1.3-fold greater
chance of re-admission within a 30-day period.
With our findings and those of others as evidence, it can be
safely assumed that prevention of leaks can save cost and
clinical burden. Potential cost reductions from preventing
anastomotic leaks could lead to a more judicious use of
hospital resources, including an increased focus on training.25
The total burden of leaks in terms of LOS per 1,000 patients
was 16,800 and 26,300 days for patients with no leaks and
with leaks, respectively (Fig. 3a). Furthermore, the average
total burden of costs per 1,000 patients was $44.3 million in
patients with no leaks as compared to $72.9 million in patients
with leaks (Fig. 3b). Based on our results, it seems evident that
there is a significant impact of anastomotic leaks on re-
admission, LOS, and total costs.
While the present study does point toward the advantages
of preventing anastomotic leaks, there are a few potential
limitations. Our study had a retrospective study design and
did not cover the management of anastomotic leaks.
Furthermore, the Premier Perspective™ database is only rep-
resentative of inpatient data from the USA. Thus, the results
from this study cannot be extrapolated as a representation of
the economic burden of anastomotic leaks in other countries.
Additionally, the classification of standardized outcome mea-
sures may have prevented analysis from any detailed
procedure-specific outcomes. Furthermore, more patients with
anastomotic leaks were discharged from the hospital to a
nursing facility other than a home. Due to the lack of outpa-
tient data in these cases, mortality may be underestimated for
patients with leaks, and this could be a cause of the small
difference observed in the in-hospital mortality between pa-
tients with and without leaks. Additionally, matched control
patients (without anastomotic leaks) had a relatively high
APR-DRG disease severity level, a strong predictor of mor-
tality; therefore, this could be a factor in the relatively high
observed mortality for matched controls. Lastly, another
potential limitation of this study is that we did not consider
open versus laparoscopic procedure as a study variable.
Conclusion
In conclusion, anastomotic leaks following colorectal surgery
increase the total clinical and economic burden by a factor of
0.6–1.9 in terms of additional 30-day re-admission, postoper-
ative infection, LOS, and hospital costs. The results of this
study underscore the potential advantages of cost reduction for
patients and hospitals by preventing anastomotic leaks after
colorectal surgery. The prevention of postoperative anasto-
motic leaks must remain a priority for healthcare providers;
this will ease a significant clinical and economic burden.
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